It is unclear how multiple sclerosis (MS) affects the severity of COVID-19. The aim of this study is to compare COVID-19-related outcomes collected in an Italian cohort of patients with MS with the outcomes expected in the age- and sex-matched Italian population.
Sormani, M.p., Schiavetti, I., Carmisciano, L., Cordioli, C., Filippi, M., Radaelli, M., et al. (2022). COVID-19 severity in multiple sclerosis: putting data into context. NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION, 9(1), e1105 [10.1212/NXI.0000000000001105].
COVID-19 severity in multiple sclerosis: putting data into context
Marfia, Girolama Alessandra;
2022-01-01
Abstract
It is unclear how multiple sclerosis (MS) affects the severity of COVID-19. The aim of this study is to compare COVID-19-related outcomes collected in an Italian cohort of patients with MS with the outcomes expected in the age- and sex-matched Italian population.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S2211034819304109-main.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
1.76 MB
Formato
Adobe PDF
|
1.76 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
